MAAUA 2021 Annual Meeting

Moderator: Jay Raman, MD

8:45 am - 9:30 am
Treatment for Low Testosterone in 2021 - Where Are We Now?
Peter Schlegel, MD

9:30 am - 9:45 am
Q&A

Moderator: Necole Streeper, MD

10:00 am - 10:15 am
US PCNL – How I Do It  
Thomas Chi, MD

10:15 am - 10:20 am
Q&A

10:20 am - 10:35 am
Tubeless PCNL/Mini Perc -outpatient
Michael Byrne, MD

10:35 am - 10:40 am
Q&A

10:40 am - 10:55 am
Percutaneous Resection of UTUC
John Knoedler, MD

10:55 am - 11:00 am
Q&A

Moderators: Daniel Lee, MD, Jeffrey Tomaszewski, MD

MP1-01

Comparative Outcomes of Salvage Retzius-sparing Versus Standard Robotic Prostatectomy: An International, Multi-Surgeon Series
Keith Kowalczyk

MP1-02

Does Deferred Prostatectomy for Grade Group 1 and 2 Increase Risk of Adverse Pathology?
Cheyenne Williams

MP1-03

Factors Associated with Use of Active Surveillance in NCCN Favorable Intermediate-Risk Prostate Cancer Patients Who Received a 17-gene Genomic Prostate Score Result
Benjamin Lowentritt, MD, FACS

MP1-04

A Review of SpaceOAR Complications and Influential Patient Characteristics
Erica Mann, MD

MP1-05

Do 5-alpha Reductase Inhibitors Effect the Diagnostic Accuracy of MRI-Fusion Biopsies?
Erica Mann, MD

MP1-06

Comparing MRI/US Fusion to Standard Prostate Biopsy in Determining Grade Reclassification at Confirmatory Biopsy in a Multi-Institutional Active Surveillance Cohort: A Pennsylvania Urology Regional Collaborative (PURC) Analysis
David Strauss, MD

MP1-07

PSA Density is Complementary to Prostate MRI PI-RADS Scoring System for Stratifying Clinically Significant Prostatic Malignancies
James Frisbie, MD

MP1-08

Sagacity of Same Day Discharge: Incidence and Timing of Postoperative Adverse Events Following Minimally Invasive Urologic Surgery
Alberto Castro Bigalli, MD, MS

MP1-09

Financial Toxicity of Prostate Cancer Survivorship: A National Cross-Sectional Assessment of Indirect Financial Burden
Christopher Herrera

MP1-10

Large Scale Implementation of Opioid Prescription Reduction after Robotic Prostatectomy – 2-Year Evaluation from the Pennsylvania Urologic Regional Collaborative (PURC)
Charles Keith

MP1-11

Analyzing Recent Medicare Reimbursement Trends in Urology
Daniel Nemirovsky

MP1-12

Racial and Stage Disparities in Increased Survival Among Patients with Metastatic Prostate Cancer in the Second-Line Antiandrogen Therapy Era
Isaac Kim, Jr., BSc

MP1-13

Gleason Upgrading Between Targeted and Systematic Template Biopsy for mpMRI PIRADS 5 Lesions
Charles Klose, MS

MP1-14

Qualitative Evaluation of Differing Opioid Sparing Protocols Across the Pennsylvania Regional Collaborative: Understanding Barriers and Facilitators
Thenappan Chandrasekar, MD

MP1-15

Existing Urine Exosome Gene Expression Signature to Assess Upgrade Risk on Radical Prostatectomy (RP)
Ronald Tutrone, MD, FACS

Moderator: Ryan Smith, MD

Point Counterpoint: Too Much Emphasis Is Given to the Semen Analysis in the Male Factor Fertility

11:00 am - 11:10 am
True: Cori Tanrikut, MD

11:10 am - 11:20 am
False: Devang Sharma, MD

11: 20 am - 11:30 am
Q&A

11:30 am - 11:50 am
Tips & Pearls in Clinical Male Infertility: What to Know?
Peter Schlegel, MD

11:50 am - 12:00 pm
Q&A

Moderator: Suzanne Merrill, MD

1:15 pm - 2:00 pm
Post Pandemic Endourology 
Thomas Chi, MD

2:00 pm - 2:15 pm
Q&A

Moderators: Justin Friedlander, MD, Rebecca Zee, MD

MP2-01

Ambulatory Percutaneous Nephrolithotomy Performed in a Free-Standing Surgery Center: Outcomes of 1000 Cases
Meagan Dunne, MD

MP2-02

Automated Machine Learning Segmentation and Measurement of Urinary Stones on CT Scan
Katerina Lembrikova

MP2-03

Use of Mini sipIT Behavioral Intervention to Increase Fluid Intake in Patients with Kidney Stones
Jason Fairbourn

MP2-04

Use of Novel Software for Predicting Outcomes Following Percutaneous Nephrolithotomy: A Pilot Study
Samay Sappal, MD

MP2-05

Comparison of Management and Outcomes of Symptomatic Urolithiasis During the COVID-19 Pandemic to a Comparative Cohort
Alex Nourian, MD

MP2-06

Post-Operative Pain and Recovery in Patients with Nephrolithiasis: Results from the Endourological Society TOWER Research Collaborative
Amanda Jones, MD

MP2-07

From Doctor Google to the App Store: Where Stone Patients Get Information
Rebecca Takele, MS

MP2-08

Identifying and Evaluating Online Kidney Stone Pain Resources
Jonathan Lim, BSc

MP2-09

Evaluation of Robotic Versus Open Approaches for Unilateral Ureteral Reimplantation in Pediatric Patients
Khaled Aldabek 

MP2-10

Surgical Correction of True Diphallia in a Newborn Male
Zachary Werner, MD

MP2-11

Implementation of a Pre-operative Testing Algorithm During the Initial COVID-19 Wave at a Rural Tertiary Care Center
Michael Mawhorter, MD

MP2-12

Provider Compliance and Clinical Outcomes Over Two Years Following Implementation of a Pre-Biopsy Rectal Swab Protocol
Amanda Seyer, MD, MEd

MP2-13

Moses Technology Improves Efficiency of Laser Lithotripsy for Patients Undergoing Mini-PCNL
Meagan Dunne, MD

Moderator: Michel Pontari, MD

2:15 pm - 3:00 pm
Evaluating the Impact of Telehealth on Access, Costs and Quality
Chad Ellimoottil, MD

3:00 pm - 3:15 pm
Q&A

Moderator: Suzanne Merrill, MD

3:45 pm - 4:30 pm
If You Want to Make an Important Discovery, Listen to your Patients
Pat Walsh, MD

4:30 pm - 4:45 pm
Q&A

Moderators: Jay Simhan, MD, Marisa Clifton, MD

Moderator: Jay Raman, MD

8:30 am - 9:15 am
Multiparametric MRI to Evaluate Renal Masses – Virtual Biopsy
Jeffrey Cadeddu, MD

9:15 am - 9:30 am
Q&A

Moderator: Krishnan Venkatesan, MD

9:45 am - 10:00 am
Evolution of Robotic Applications in Urologic Reconstruction
Dan Eun, MD

10:00 am - 10:10 am
Q&A

10:10 am - 10:25 am
Applications and Challenges in Robotics in Pediatric Urology
Arun Srinivasan, MD 

10:25 am - 10:35 am
Q&A

10:35 am - 10:50 am
Robotics in Gender Affirmation Surgery
Ross Krasnow, MD, MPH

10:50 am - 11:00 am
Q&A

Moderators: Ahkil Das, MD, Mikel Gray, PhD, CUNP, Nicolas Ortiz, MD

MP3-01

Morbidity of Bladder Outlet Obstruction Treatment Following Radiotherapy for Prostate Cancer
Monika Tedeschi, MD

MP3-02

Evaluating Patient Priorities in Benign Prostatic Hyperplasia Treatment Using Conjoint Analysis
Phillip Huffman

MP3-03

Outcomes of Prostatic Urethral Lift (PUL) are Consistent Across Heterogenous Patient Populations in the Real World
Thomas Mueller, MD

MP3-04

Sizeable data for Prostatic Urethral Lift (PUL) in Retention Patients: 12-Month Outcomes from the Large Real-World Study and Urodynamic Results from PULSAR Demonstrate PUL is Safe and Effective
Gregg Eure, MD

MP3-05

Comparison of Rezum versus Urolift in the Management of Benign Prostatic Hypertrophy
Prisca Alilio

MP3-06

Bleeding Risk with Aquablation Stratified by Prostate Size: A Single Center Experience
Johnathan Drevik, MS, MD

MP3-07

Relationship Between Overactive Bladder Symptom Severity and Cystometric Bladder Capacity in Patients with Overactive Bladder
Katerina Lembrikova

MP3-08

Stress Incontinence Outcomes Following Robotic Prostatectomy: Interim Analysis of Novel Pelvic Floor Program
Jacques Farhi, MD, MBA

MP3-09

Post-Phalloplasty Urinary Function Test: A Novel Outcome Instrument to Capture Urinary Dysfunction and Quality of Life after Phalloplasty
James Liu, MD

MP3-10

Adherence with Imaging and Treatment Recommendations Following Urodynamics Testing in Patients with Neurogenic Bladder
Alice Xiang, MD

MP3-11

The Underachieving Results for Overactive Bladder
Tyler Trump, MD

MP3-12

The Natural History of Urinary Retention following in Patients Admitted to Inpatient Rehabilitation After Acute Neurologic Insult
Andrew Higgins, MD

MP3-13

Patient Perceptions of Pelvic Organ Prolapse Education Techniques
Elizabeth Corley

Moderator: Rena Malik, MD

11:00 am - 11:15 am
Bulking Agents
Kathleen Kobashi, MD

11:15 am - 11:30 am
Implantable PTNS
Ariana Smith, MD

11:30 am - 11:45 am
Sacral Neuromodulation
Joe Littlejohn, MD

11:45 am - 12:00 pm
Q&A

Moderators: Michael Pontari, MD

1:15 pm - 1:30 pm
Telehealth
Jennifer Bepple, MD

1:30 pm - 1:35 pm
Q&A

1:35 pm - 1:50 pm
New CMS
Jonathan Rubenstein, MD

1:50 pm - 2:00 pm
Q&A

Moderators: Thenappan Chandrasekar, MD, Rosalia Viterbo, MD

MP4-01

Association of Tumor Size and Surgical Approach with Oncological Outcomes in Patients with Adrenocortical Carcinoma
Alberto Castro Bigalli, MD, MS

MP4-02

Residual/Upgraded Disease at Time of re-TUR when Bluelight Cystoscopy used as Primary Procedure for Non-Muscle Invasive Bladder Carcinoma
Alanna Cruz-Bendezu

MP4-03

Social Factors Influence Treatment Decisions in Node-Positive Non-Metastatic Bladder Cancer
Tyler Trump, MD

MP4-04

Treatment Failure and Disease Progression of Non-Muscle Invasive Bladder Cancer During BCG Shortage
Andrew Salib, MD

MP4-05

Management of Non-Muscle Invasive Bladder Cancer in a Time of BCG Shortage
Raju Chelluri, MD

MP4-06

Physicians’ Knowledge About Pembrolizumab for High-Risk Non-Muscle Invasive Bladder Cancer: Quality Improvement Targets in Multidisciplinary Cancer Care
Ruchika Talwar, MD

MP4-07

Robotic-Assisted Laparoscopic Approach to Radical Cystectomy Mitigates Surgical Complications in Patients with Preoperative Malnutrition
Cyrus Adams-Mardi, MS

MP4-08

Rising Rates of Newly Diagnosed Testicular Cancer: 27-Year Trends from a Statewide Registry
Ahmad Alzubaidi, MD

MP4-09

Urological Management of Incarcerated Persons with Testicular Malignancy at a Single Institution
William Visser, MD

MP4-10

Survival Outcomes in Late, Intermediate and Early Recurrence Renal Cell Carcinoma
Mary Rostom

MP4-11

Surgical Delay After Biopsy and Risk of Upstaging for Clinical T1a Renal Cell Carcinoma
Leilei Xia, MD

MP4-12

Percutaneous Microwave Ablation vs Partial Nephrectomy for Small Renal Masses: Cost-Effectiveness Analysis
Clinton Yeaman, MD, MS

MP4-13

Characterizing Tumor Thrombus Arising from Non Clear Cell Renal Cell Carcinoma
Matthew Rabinowitz

MP4-14

Renal Functional Outcomes after Robotic Assisted Laparoscopic Partial Nephrectomy for Single vs Multiple Renal Tumors
Srikar Kuppa

MP4-15

Distribution of New Renal Cell Carcinoma Cases Across A Large Statewide Cancer Registry
Ahmad Alzubaidi, MD

 Moderator: Suzanne Merrill, MD

2:00 pm - 2:45 pm
Refractory OAB and What is on the Horizon
Kathleen Kobashi, MD

2:45 pm - 3:00 pm
Q&A

Moderator: Sanford Siegel, MD

Panelists: Jennifer Miles-Thomas, MD, Matthew Meissner, MD, Ruchika Talwar, MD, Rob Uzzo, MD

Moderators: Brant Fulmer, MD, Edouard Trabulsi, MD

V-01

Diagnosis and Treatment of Pelvic Organ Prolapse Following Radical Cystectomy
Meghan Davis, MD, MPH

V-02

Use of SPY Fluorescent Angiography During Urinary Diversion
Grace Prillaman

V-03

Step-by-Step Robotic Ureteral Re-implantation: Intravesical and Extravesical Techniques
Srikar Kuppa

V-04

Robotic Ureteral Reconstruction for Management of a Recurrent Stricture After Prior Ureterocalicostomy
Matthew Lee, MBA

V-05

Intraoperative Management of Incidentally Identified Right Ectopic Ureter Inserting at Bladder Neck During RALP
Ahmad Alzubaidi, MD

V-06

Combined Robotic and Endoscopic Pyelolithotomy in a Pelvic Kidney
Andrew Higgins, MD

V-07

Robotic Assisted Laparoscopic Takedown of an Entero-Ileal Conduit Fistula
Daniel Roberson, MD

Moderator: Tracy Krupski, MD

Panelists: Jeffery Cadeddu, MD, Mark Ball, MD, Matthew Kaag, MD

Moderator: Suzanne Merrill, MD

9:00 am - 9:45 am
Recurrent UTIs in Women: Ask the Guideline
Jennifer Anger, MD 

9:45 am - 10:00 am
Q&A

Moderators: Joe Littlejohn, MD, Daniel Stein, MD

MP5-01

The Effect of 3D Printed Models on Surgical Planning and Outcomes for Partial Nephrectomies
Andrea Quinn

MP5-02

Using Resident Evaluators Provides Less Anxiety When Implementing Novel Technical Skills Assessments During Residency Interviews
Ahmad Alzubaidi, MD

MP5-03

Nephrolithiasis Nutritional Counseling: Comparison of Patient Satisfaction between Face-to-Face and Telehealth Modalities
Kayla Schilling

MP5-04

The Utilization of Perfused Cadaver Simulation in Urologic Training
Daniel McClelland, MD

MP5-05

Wellness Programming in Urology Residency Programs
Haritha Pavuluri, MS

MP5-06

Difficult Foley? A Look into Difficult Foley Consults
Katharina Mitchell, MD

MP5-07

The Outcome of Utilizing Robotic Surgical System to Treat Ureteroenteric Anastomotic Stricture
Ahmad Dahman, MD

MP5-08

Ureteral Stricture Prevention Through a Multi-modal Intervention for Robotic Intracorporeal Ileal Conduit Urinary Diversion
Shu Wang, MD

MP5-09

HOLEP Perioperative Outcomes Using Three Different Holmium Laser Technologies in a Community Hospital Setting
Michael Li, MS

MP5-10

Urology Practice Scores in the Era of the Merit-based Incentive Payment System
Ridwan Alam, MD, MPH

MP5-11

Telehealth in Urology 1-year into the Pandemic: Sustained Change or a Flash in the Dark
Ahmad Alzubaidi, MD

MP5-12

The Delayed and Diminished Nephrogram on Computed Tomography: Measurement and Association with Impaired Renal Function
Matthew Loecher, MD

MP5-13

Contrast-Enhanced 4D Ultrasonography for the Evaluation of Complex Renal Cysts
Erica Mann

Moderators: Adam Luchey, MD

10:15 am - 10:30 am
Understanding and Managing BCG Unresponsive Non-muscle Invasive Bladder Cancer
Stephen Boorjian, MD

10:30 am - 10:35 am
Q&A

10:35 am - 10:50 am
Application of BLC and Novel TUR Techniques
Max Kates, MD 

10:50 am - 10:55 am
Q&A

10:55 am - 11:10 am
Management of Long-Term Complications of Urinary Diversions for NMBIC Necessitating Cystectomy
Minhaj Siddiqui, MD

11:10 am - 11:15 am
Q&A

Moderator: Suzanne Merrill, MD

11:15 am - 11:35 am
2021 Priapism Guidelines
Trinity Bivalacqua, MD, PhD

11:35 am - 12:00 pm
2021 Renal Mass (Amendment)
Mohamad Allaf, MD

Moderators: Elizabeth T. Brown, MD, MPH, R. Caleb Kovell, MD

1:15 pm - 1:25 pm

RPE-01: Diagnostic Dilemmas: A Multi-Institutional Retrospective Analysis of Adrenal Incidentaloma Pathology Based on Radiologic Size
David Zekan, MD

1:25 pm - 1:35 pm

RPE-02: Risk of Secondary Malignancies After Pelvic Radiation: A Population-Based Analysis
Andrew Salib, MD

1:35 pm - 1:45 pm

RPE-03: Don’t Skirt the Question: Lead Bed Skirts in the OR, an Intervention
Jacob Thatcher, DO

1:45 pm - 1:55 pm

RPE-04: Harnessing Choice Architecture in Urologic Practice: Implementation of an Opioid-Sparing Protocol Grounded in Cognitive Behavioral Theory
Alex Nourian, MD

1:55 pm - 2:05 pm

RPE-05: The Impact of COVID-19 on Urologic Surgery Residency and Wellbeing In The US and EU
Charlotte Goldman, MD

2:05 pm - 2:15 pm

RPE-06: Surgical Preparation in the Next Generation: YouTube Domination?
Joshua Eccles, MD

Moderators: Andrew Cohen, MD, Ronak Gor, MD

MP6-01

Effects of 2-Years Oral Testosterone Undecanoate (TU) Administration (JATENZO®) on Liver Function and Other Safety Measures in Hypogonadal Men
Marc Gittelman, MD

MP6-02

Inflatable Penile Prosthesis Patients Treated with Multimodal Analgesia Have Reduced Risk of Prolonged Opioid Dependence
Avery Braun, DO

MP6-03

Does A Preemptive Quality of Life Clinic Increase Utilization of Treatment Options Following Radical Prostatectomy?
Paul Prillaman

MP6-04

A Comparison of the Psychosocial Impact of Penile Implant and Intracavernosal Injection Therapy for Erectile Dysfunction Using the Self-Esteem and Relationship (SEAR) Questionnaire
Andrew Salib, MD

MP6-05

Patterns Of Surgical Management of Male Stress Urinary Incontinence: Data from the AUA Quality (AQUA) Registry
Hasan Dani, MD

MP6-06

A Comparison of Hospital Charges Between Secondary Robotic Pyeloplasty and Chronic Ureteral Stenting for Management of Recurrent Ureteropelvic Junction Obstruction
Matthew Lee, MBA

MP6-07

Surgical Planning for Urethral Reconstruction: Is Retrograde Urethrogram Alone Sufficient
Catherine Robey, MA, MD

MP6-08

General Surgeons’ Comfort and Urologists’ Perceptions of Bladder Trauma Management
Joon Yau Leong, MD

MP6-09

Multi-Institutional Comparison of Non-Transecting Versus Transecting Primary Robotic Pyeloplasty for Ureteropelvic Junction Obstruction
David Strauss, MD

MP6-10

Demucosalized Detrusor Muscle Flaps for Management of Complex Urethral Fistula
Matthew Loecher, MD

MP6-11

Robotic Approach for Distal Ureteral Reconstruction in Post-Radiation Ureteral Stricture
Amr Elbakry, MD

MP6-12

Effect of Urology Consult on Renal Trauma Outcomes
Shirley Wang

MP6-13

Characterizing the Epidemiology and Management of Urological Trauma in Baltimore, Maryland
Isabella Pan

Moderator: Costas Lallas, MD

Panelists: David Chen, MD, Pamela Coleman, MD, Armine Smith, MD

Moderator: Jay Raman, MD

3:30 pm - 4:15 pm
Contemporary Surgical Management of High-Risk Prostate Cancer: Pre-, Intra-, and Post-operative Considerations 
Stephen Boorjian, MD

4:15 pm - 4:30 pm
Q&A

Moderator: Chad Morley, MD

4:30 pm - 4:42 pm
UTUC
Phil Pierorazio, MD

4:42 pm - 4:45 pm
Q&A

4:45 pm - 4:57 pm
BPH
Steven Sterious, MD

4:57 pm - 5:00 pm
Q&A

5:00 pm - 5:12 pm
Men’s Health
Susan MacDonald, MD

5:12 pm - 5:15 pm
Q&A

DP-01
Persistence of Opioid Reduction Habits 1 Year After Implementation
Andrea Quinn

DP-02
More Stress or Relief?: Patient Perceptions of Oncologic Follow-up After Surgery for Urologic Malignancies
Sarah Strausser

DP-03
Concurrent Nephrolithiasis During Partial Nephrectomy: A Multi-Institution Retrospective Analysis of Post-Operative Complications
Andrew Garcia, PharmD

DP-04
Perioperative Cost Comparison Between Percutaneous Microwave Ablation vs Partial Nephrectomy for Small Renal Masses
Clinton Yeaman, MD, MS

DP-05
Single Institution Review of Prevena Epidermal Wound Vacuum Usage in Patients undergoing Inguinal Lymph Node Dissection for Penile Cancer
Jacques Farhi, MD, MBA

DP-06
Decreased Inpatient Opioid Exposure After Robot Prostatectomy with Implementation of Opioid Stewardship Protocols– 2 Year Evaluation from the Pennsylvania Urologic Regional Collaborative (PURC)
Adrien Bernstein, MD

DP-07
Influence of Patient Clinicopathologic Variables on Prostate Tumor Upgrading at Radical Prostatectomy
Benjamin McSweeney

DP-08
Active Surveillance or Watchful Waiting in Clinically Low-Risk Prostate Cancer Patients in the SEER Database with and without an Oncotype DX Genomic Prostate Score Assay
Yao Yuan, MPH, PhD

DP-09
Comparison of Highest-Grade Tumor Percentage in Core Samples from MRI-targeted Biopsy and Systematic Biopsy for Prostate Cancer Diagnosis
Shu Wang, MD

DP-10
Early Return to Continence Preserved with Suprapubic Catheter Following Retzius-sparing Prostatectomy
Samuel Engelsgjerd, MD

DP-11
Evaluating Factors Associated with Emergency Department Visits within 30 Days Following Elective Ureteroscopy for Nephrolithiasis
Jennifer Kane

DP-12
Utilization of Ambulatory Surgery Center and Acute Management Pathway to Improve Stone Treatment Time
Andrew Wang, MD

DP-13
4 Week Virtual Urology Course Focused on Teaching Non-Urology Students
Andrea Quinn

DP-14
Trends in Hospital Opioid Use after Urological Trauma
Mary Rostom

DP-15
Preoperative Predictors of Surgical Success for Robotic Ureteral Reconstruction of Proximal and Middle Ureteral Strictures
Matthew Lee, MBA

DP-16
Shear Wave Elastography: Novel Methods for the Evaluation of Urethral Stricture Disease
Joon Yau Leong, MD

DP-17
Utilizing da Vinci ® Robotic Surgical System to treat Distal Ureteral Cancer, Functional and Oncological Outcome
Ahmad Dahman, MD

DP-18
The Social Impact of Surgery for Nephrolithiasis: Results from the Endourological Society TOWER Research Collaborative
Amanda Jones, MD

DP-19
Widening of Socioeconomic Disparities After the USPSTF’s 2012 Prostate-Specific Antigen-Based Prostate Cancer Screening Recommendation
Isaac Kim, Jr., MD, PhD, MBA, FACS

DP-20
Same-Day Discharge and Post-discharge Outcomes after Robot-assisted Radical Prostatectomy
Leilei Xia, MD